Literature DB >> 15689155

Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors.

Stefan A Laufer1, David M Domeyer, Thomas R F Scior, Wolfgang Albrecht, Dominik R J Hauser.   

Abstract

On the basis of ATP adenine, a series of adenine and purine derivatives was prepared and tested for their ability to inhibit a spectrum of disease-related kinases. There has been scant research investigating the potential of cosubstrate derived kinase inhibitors for other kinases than CDKs. Our inhibitor design combined the purine system from the original cosubstrate ATP and phenyl moieties in order to explore possible interactions with the different regions of the ATP binding site in several disease-related protein kinases. There have been a number of hits for the assayed substances, which led us to conclude that the spectrum of compounds may prove to be a valuable tool kit for the evaluation of bonding and selectivity patterns for a wide variety of kinases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15689155     DOI: 10.1021/jm0408767

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

1.  N⁴-(3-Bromophenyl)-7-(substituted benzyl) pyrrolo[2,3-d]pyrimidines as potent multiple receptor tyrosine kinase inhibitors: design, synthesis, and in vivo evaluation.

Authors:  Aleem Gangjee; Nilesh Zaware; Sudhir Raghavan; Jie Yang; Jessica E Thorpe; Michael A Ihnat
Journal:  Bioorg Med Chem       Date:  2012-02-04       Impact factor: 3.641

2.  Synthesis and biological activity of 5-chloro-N⁴-substituted phenyl-9H-pyrimido[4,5-b]indole-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic agents.

Authors:  Aleem Gangjee; Nilesh Zaware; Sudhir Raghavan; Bryan C Disch; Jessica E Thorpe; Anja Bastian; Michael A Ihnat
Journal:  Bioorg Med Chem       Date:  2013-01-31       Impact factor: 3.641

3.  Sustainable synthesis and automated deposition: an accessible discovery screening library of fragment-like purines.

Authors:  Christoph Kamper; Katharina Korpis; Edgar Specker; Lennart Anger; Martin Neuenschwander; Patrick J Bednarski; Andreas Link
Journal:  Mol Divers       Date:  2012-08-14       Impact factor: 2.943

Review 4.  Synthesis of histidine kinase inhibitors and their biological properties.

Authors:  Miyanou Rosales-Hurtado; Patrick Meffre; Hendrik Szurmant; Zohra Benfodda
Journal:  Med Res Rev       Date:  2019-12-05       Impact factor: 12.944

5.  Rational Design of Selective Adenine-Based Scaffolds for Inactivation of Bacterial Histidine Kinases.

Authors:  Manibarsha Goswami; Kaelyn E Wilke; Erin E Carlson
Journal:  J Med Chem       Date:  2017-10-03       Impact factor: 7.446

6.  Structure-metabolism relationships in human-AOX: Chemical insights from a large database of aza-aromatic and amide compounds.

Authors:  Susan Lepri; Martina Ceccarelli; Nicolò Milani; Sara Tortorella; Andrea Cucco; Aurora Valeri; Laura Goracci; Andreas Brink; Gabriele Cruciani
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-03       Impact factor: 11.205

7.  "Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists.

Authors:  Melissa Perreira; Jian-Kang Jiang; Athena M Klutz; Zhan-Guo Gao; Asher Shainberg; Changrui Lu; Craig J Thomas; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

8.  3-(2-Fluoro-phen-yl)-6-(phenoxy-meth-yl)-1,2,4-triazolo[3,4-b][1,3,4]thia-diazole.

Authors:  Melanie Holm; Dieter Schollmeyer; Stefan Laufer
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-03-12

9.  Single agents with designed combination chemotherapy potential: synthesis and evaluation of substituted pyrimido[4,5-b]indoles as receptor tyrosine kinase and thymidylate synthase inhibitors and as antitumor agents.

Authors:  Aleem Gangjee; Nilesh Zaware; Sudhir Raghavan; Michael Ihnat; Satyendra Shenoy; Roy L Kisliuk
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

10.  The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents.

Authors:  Xin Zhang; Sudhir Raghavan; Michael Ihnat; Jessica E Thorpe; Bryan C Disch; Anja Bastian; Lora C Bailey-Downs; Nicholas F Dybdal-Hargreaves; Cristina C Rohena; Ernest Hamel; Susan L Mooberry; Aleem Gangjee
Journal:  Bioorg Med Chem       Date:  2014-05-14       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.